临床试验/JPRN-UMIN000053444

JPRN-UMIN000053444已完成未知

24-hour closed patch test of Defying serum and Correcting serum together with 2 controls - Closed patch test of Defying serum and Correcting serum

Shiba Palace Clinic0 个研究点目标入组 20 人开始时间: 2024年2月1日最近更新: 2024年5月27日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方: Shiba Palace Clinic
入组人数: 20

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 20years-old 至 60years-old（—）
性别: All

入选标准

未提供

排除标准

•1) Subjects with skin hypersensitivity 2) Subjects with contact allergy or those who are likely to have allergic symptoms 3) Subjects who are taking or applying drugs that are likely to affect the test results 4) Subjects currently attending dermatology department 5) Subjects who are pregnant or may be pregnant, and those who are breastfeeding 6) Subjects who are not suitable for patch tests due to acne, pimples (wide range), spots (wide range), scratches, tattoos, warts, burn marks, etc. at the test sites 7) Subjects who has anamnesis or current disease that seem to be inappropriate for patch tests

研究者

发起方

Shiba Palace Clinic

相似试验

To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch TestSkin Care

NCT03233009GlaxoSmithKline43

Repeat closed patch test study to evaluate the irritation test materials by repeated insult patch test method by pasting patch on the upper back of healthy human subjects.

CTRI/2012/12/003233KAYA Limited50

Patch test of skin external preparations.Healthy adults.

JPRN-UMIN000021791Yaesu Nihonbashi Skin Clinic10

Routine kidney function test in patients before undergoing minor and intermediate risk surgeries

CTRI/2023/09/057369Dr Anusha M S

Exploratory clinical trial of serum-, and feeder cell-free cultivated autologous corneal limbal epithelial cell sheet transplantation using human amniotic membrane for corneal epithelial stem-cell deficiencynilateral corneal epithelial stem cell deficiency: Patients who have dysfunction of the entire limbus with almost replaced by conjunctival epithelium, neovascularization and corneal scarring tissue.

JPRN-UMIN000012014Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo3